Cite
ACE I/D Polymorphism, Plasma ACE Levels, and Long-term Kidney Outcomes or All-Cause Death in Patients With Type 1 Diabetes.
MLA
Abouleka, Yawa, et al. “ACE I/D Polymorphism, Plasma ACE Levels, and Long-Term Kidney Outcomes or All-Cause Death in Patients With Type 1 Diabetes.” Diabetes Care, vol. 44, no. 6, June 2021, pp. 1377–84. EBSCOhost, https://doi.org/10.2337/dc20-3036.
APA
Abouleka, Y., Mohammedi, K., Carpentier, C., Dubois, S., Gourdy, P., Gautier, J.-F., Roussel, R., Scheen, A., Alhenc-Gelas, F., Hadjadj, S., Velho, G., & Marre, M. (2021). ACE I/D Polymorphism, Plasma ACE Levels, and Long-term Kidney Outcomes or All-Cause Death in Patients With Type 1 Diabetes. Diabetes Care, 44(6), 1377–1384. https://doi.org/10.2337/dc20-3036
Chicago
Abouleka, Yawa, Kamel Mohammedi, Charlyne Carpentier, Severine Dubois, Pierre Gourdy, Jean-François Gautier, Ronan Roussel, et al. 2021. “ACE I/D Polymorphism, Plasma ACE Levels, and Long-Term Kidney Outcomes or All-Cause Death in Patients With Type 1 Diabetes.” Diabetes Care 44 (6): 1377–84. doi:10.2337/dc20-3036.